Business Description
IDEXX Laboratories Inc
NAICS : 325412
SIC : 2835
ISIN : US45168D1046
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.72 | |||||
Debt-to-EBITDA | 0.88 | |||||
Interest Coverage | 26.39 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 17.76 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EBITDA Growth Rate | 16.7 | |||||
3-Year EPS without NRI Growth Rate | 14.8 | |||||
3-Year FCF Growth Rate | 13.9 | |||||
3-Year Book Growth Rate | 34.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.59 | |||||
9-Day RSI | 14.51 | |||||
14-Day RSI | 21.18 | |||||
6-1 Month Momentum % | 24.57 | |||||
12-1 Month Momentum % | 9.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.48 | |||||
Days Inventory | 95.69 | |||||
Days Sales Outstanding | 44.24 | |||||
Days Payable | 27.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1 | |||||
Shareholder Yield % | 0.86 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.82 | |||||
Operating Margin % | 29.97 | |||||
Net Margin % | 23.08 | |||||
FCF Margin % | 21.11 | |||||
ROE % | 79.34 | |||||
ROA % | 28.6 | |||||
ROIC % | 36.34 | |||||
ROC (Joel Greenblatt) % | 92.26 | |||||
ROCE % | 57.05 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 47.43 | |||||
Forward PE Ratio | 43.67 | |||||
PE Ratio without NRI | 47.2 | |||||
Shiller PE Ratio | 81.01 | |||||
Price-to-Owner-Earnings | 55.57 | |||||
PEG Ratio | 2.64 | |||||
PS Ratio | 10.96 | |||||
PB Ratio | 26.72 | |||||
Price-to-Tangible-Book | 38.35 | |||||
Price-to-Free-Cash-Flow | 51.89 | |||||
Price-to-Operating-Cash-Flow | 44.25 | |||||
EV-to-EBIT | 36.53 | |||||
EV-to-Forward-EBIT | 34.07 | |||||
EV-to-EBITDA | 33.08 | |||||
EV-to-Forward-EBITDA | 30.38 | |||||
EV-to-Revenue | 11 | |||||
EV-to-Forward-Revenue | 10.17 | |||||
EV-to-FCF | 52.12 | |||||
Price-to-Projected-FCF | 4.8 | |||||
Price-to-DCF (Earnings Based) | 1.51 | |||||
Price-to-DCF (FCF Based) | 1.79 | |||||
Price-to-Median-PS-Value | 1.19 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.59 | |||||
Price-to-Graham-Number | 8.96 | |||||
Earnings Yield (Greenblatt) % | 2.74 | |||||
FCF Yield % | 1.95 | |||||
Forward Rate of Return (Yacktman) % | 19.48 |